NMTC.NASDAQNeuroone Medical Technologies CORP

SCHEDULE: Sio Capital Reduces NeuroOne Medical Stake Below 5%

Sentiment:

Beneficial Ownership Report

📋All filings for Neuroone Medical Technologies CORP
🔒Login to Follow

Sio Capital Management, LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 4.72% in NeuroOne Medical Technologies Corp as of September 30, 2025.

Worse than expectedSio Capital Management, LLC's beneficial ownership decreased to 4.72%, falling below the 5% threshold, which may signal reduced institutional interest or a portfolio adjustment.

Summary

  • Sio Capital Management, LLC reported beneficial ownership of 2,360,635 shares of NeuroOne Medical Technologies Corp common stock.
  • This ownership represents 4.72% of the outstanding common shares.
  • The filing is an Amendment No. 1 to a Schedule 13G, indicating a change in ownership from a previous filing, bringing the stake below the 5% threshold.
  • Sio Capital Management, LLC, as a registered investment adviser, holds these shares for certain affiliated funds and exercises shared voting and dispositive power.
  • The percentage of class is calculated based on 49,999,519 common shares outstanding as of August 12, 2025.

Sentiment

Score: 4

Explanation: The filing indicates a reduction in institutional ownership below the 5% threshold, which is generally viewed as a slightly negative signal for the issuer, suggesting a potential decrease in investor conviction or a portfolio rebalancing by Sio Capital Management, LLC.

Negatives

  • Sio Capital Management, LLC's beneficial ownership has decreased to 4.72%, falling below the 5% threshold typically associated with significant institutional stakes, which could be interpreted as a reduction in conviction or a portfolio rebalancing.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may perceive a reduction in institutional ownership as a negative signal, potentially influencing stock price or investor confidence.

Key Dates

DateDescription
August 12, 2025Date on which 49,999,519 common shares of NeuroOne Medical Technologies Corp were outstanding, as disclosed in the Issuer's 10-Q.
September 30, 2025Date of the event which required the filing of this statement, reflecting Sio Capital Management, LLC's beneficial ownership.
October 31, 2025Date the Schedule 13G Amendment No. 1 was signed and filed.

Recommendation

hold

The reduction in Sio Capital Management, LLC's stake below 5% suggests a potential decrease in institutional conviction or a portfolio rebalancing. While not a definitive 'sell' signal, it warrants a 'hold' recommendation as investors should monitor future institutional ownership changes and the company's operational performance for further clarity.

Keywords

NeuroOne Medical Technologies Corp, Sio Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Medical Technology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.